Core Viewpoint - The Heze Luxi New Area has made significant progress in drug safety regulation and industry development, addressing public concerns and enhancing safety awareness through various initiatives [1][5]. Group 1: Drug Safety Regulation - The Luxi New Area has implemented a dual approach of "promotion + training" to enhance public and industry personnel's safety awareness, conducting multiple public outreach events and training sessions [2]. - A comprehensive regulatory system has been established, focusing on risk management and local oversight, with over 1,600 law enforcement personnel deployed to inspect 463 drug operating units this year [3]. - The "Code for Assurance" platform has achieved a 100% registration rate for drug operating units, ensuring traceability and quality control of drugs [3]. Group 2: Industry Development - The biopharmaceutical industry is a key sector in the Luxi New Area, with several major projects completed and new investments signed, totaling 7.51 billion yuan this year [4]. - The area has facilitated the growth of retail pharmacy chains, with 282 drug retail enterprises and a chain rate of 86%, promoting scale and efficiency in the industry [5]. Group 3: Public Engagement and Compliance - The Luxi New Area has strengthened online drug sales regulation, achieving a 100% inspection coverage of 149 online sales enterprises, while advising consumers to purchase from legitimate platforms [5]. - Future efforts will focus on enhancing regulatory services and encouraging public participation in drug safety governance, fostering a collaborative environment for high-quality industry development [5].

Core Viewpoint - The Ordos Market Supervision Administration is implementing multiple measures to strengthen the supervision and management of narcotic and psychotropic drugs, ensuring public safety and health [1][2] Group 1: Regulatory Actions - The "Qingyuan 2025" special action plan has been developed to clarify the focus and division of tasks for the supervision of narcotic and psychotropic drugs [1] - There is an emphasis on enhancing supervision of special drug raw materials and outpatient treatment for drug addiction, preventing illegal circulation of these drugs [1] - Comprehensive inspections of drug operating and using units are being conducted, focusing on the qualifications, sales channels, storage conditions, and usage records of narcotic drugs [1] Group 2: Risk Management - A risk consultation meeting has been organized to identify risk points in the circulation and use of narcotic drugs, leading to the formulation of targeted control measures [1] - Ongoing monitoring and special rectification efforts are being strengthened, particularly in medical institutions regarding the management of narcotic drugs and monitoring of drug abuse [1] - As of now, 327 medical institutions have been inspected, with 825 law enforcement personnel deployed to address issues related to expired narcotic drugs [1] Group 3: Online and Offline Monitoring - There is a continuous effort to monitor and combat the illegal online sale of narcotic drugs, with both online inspections and third-party monitoring being conducted [2] - No illegal sales of narcotic drugs through the internet have been found in the Ordos area to date [2] - Future actions will include enhancing follow-up inspections of medical institutions, improving risk prevention mechanisms, and strengthening online regulatory measures [2]

Core Viewpoint - The article emphasizes the importance of drug safety in rural areas and outlines measures taken by the Shawan City Market Supervision Administration to enhance drug safety and protect public health [1][2]. Group 1: Regulatory Measures - The Shawan City Market Supervision Administration has implemented a three-pronged regulatory model of "daily supervision + special rectification + smart regulation" to increase inspection frequency and intensity for rural drug businesses [1]. - Key areas of focus include the inspection of expired drugs and counterfeit products, with a full-chain supervision approach covering procurement, storage, and sales [1]. - The administration aims to create a high-pressure environment for illegal activities by ensuring that every violation is discovered and dealt with promptly [1]. Group 2: Service Improvement - Efforts are being made to enhance drug accessibility by guiding chain pharmacies to expand supply channels in rural areas, allowing residents to purchase safe and affordable medications locally [2]. - Training programs for drug businesses are being conducted to improve the standardization of drug storage and sales practices, as well as to enhance the professional skills of staff [2]. Group 3: Community Engagement - The article highlights the importance of public participation in drug safety, with regular outreach activities to educate the community about drug safety laws and regulations [2]. - A collaborative governance model is being promoted, involving regulatory authorities, business self-discipline, and public participation to eliminate counterfeit drugs in rural areas [2]. Group 4: Future Directions - The Shawan City Market Supervision Administration plans to continue focusing on weak links in rural drug safety, improving regulation, enhancing services, and strengthening public awareness [2]. - The goal is to ensure that rural residents feel a greater sense of security, happiness, and satisfaction regarding drug safety [2].

Core Viewpoint - The E'min County Market Supervision Administration is committed to maintaining drug market order and ensuring drug safety through regular and detailed inspections of pharmacies and medical institutions [1][2] Group 1: Regulatory Focus - The administration emphasizes three core areas during inspections of retail pharmacies: compliance with qualifications, operational standards, and quality control [1] - Inspections include verifying the validity of drug operation licenses and ensuring that pharmacists are present and following proper prescription protocols [1] - The storage conditions of drugs are also scrutinized, ensuring that cold storage temperatures meet standards and that drugs are stored according to regulations to prevent quality issues [1] Group 2: Medical Institutions Oversight - The administration focuses on traceability of sources, quality control, and compliance in the procurement and use of drugs and medical devices in medical institutions [1] - Key checks include ensuring that medical institutions purchase drugs and devices from legal channels and do not use expired or unqualified products [1] Group 3: Approach to Regulation - The administration adopts a dual approach of service and regulation, combining education with enforcement, addressing minor issues with on-the-spot guidance and taking legal action against violations [2] - Future plans include maintaining a high-pressure regulatory stance through regular inspections and follow-up checks to reinforce regulatory effectiveness [2]

Group 1 - The core theme of the article is "Drug Safety and Regulation for the People," focusing on integrating drug safety knowledge dissemination with drug safety rectification efforts [1] - The initiative includes outreach to schools, communities, and enterprises to enhance public awareness of drug safety [1] - The approach involves interactive methods such as storytelling and Q&A sessions in schools, practical examples in communities, and integrating safety education into regulatory inspections in enterprises [1] Group 2 - The next steps involve deepening the integration of drug safety promotion with daily regulatory practices, ensuring that supervision and public education are synchronized [1] - The goal is to extend the reach of drug safety education to all areas where regulation occurs, reinforcing the message that "where regulation extends, promotion will cover" [1] - This strategy aims to strengthen drug safety measures and create a solid foundation for maintaining a good drug safety environment [1]

Core Viewpoint - The article highlights the efforts of the Yuhang District Market Supervision Administration to enhance drug safety regulation in small pharmacies, clinics, and beauty shops, focusing on protecting public health through targeted governance measures [1][2]. Group 1: Regulatory Measures - The Yuhang District Market Supervision Administration has initiated a special governance campaign targeting "three smalls" (small pharmacies, small clinics, small beauty shops) to address drug safety concerns [1]. - A dynamic electronic file system has been established for 1,155 "three smalls" units, including 313 small pharmacies, 182 small clinics, and 660 small beauty shops, integrating various regulatory data for precise monitoring [2]. - The administration has identified 79 key regulatory targets, increasing the frequency and rigor of inspections for these entities [2]. Group 2: Compliance and Rectification - A closed-loop mechanism has been created, consisting of a subject information list, problem list, and rectification list, ensuring that all issues are tracked and resolved online [4]. - The administration has conducted eight inspection campaigns, resulting in legal penalties for 30 entities, including 14 beauty shops, 9 clinics, and 7 pharmacies, to enforce accountability [4]. - A total of 132 identified issues have been fully rectified, demonstrating the commitment to drug safety [4]. Group 3: Support for Operators - The Yuhang District has organized training and collective discussions for over 400 operators of "three smalls," clarifying key regulations such as the Drug Administration Law and negative lists [4]. - The administration has implemented measures to strengthen social supervision, including signing responsibility agreements and providing public reporting channels [4]. - The approach combines digital governance with human-centered guidance to foster trust in drug safety [4].

Core Viewpoint - The National Medical Products Administration (NMPA) announced the "National Drug Safety Publicity Week" for 2025, scheduled from September 1 to 7, with the theme "Drug Safety Regulation for the People" [1] Group 1 - The 2025 event marks the end of the 14th Five-Year Plan and signifies a new phase in deepening drug regulatory reforms [1] - The focus will be on showcasing the achievements of drug regulation since the establishment of the NMPA, particularly during the 14th Five-Year Plan period [1] - The initiative aims to enhance public trust and support for drug regulation efforts, emphasizing high-level safety and the promotion of high-quality development in the pharmaceutical industry [1] Group 2 - The campaign will include extensive public education on the safety of "two drugs and one device" (referring to drugs and medical devices), utilizing various formats to disseminate related scientific knowledge [1] - The goal is to improve public scientific literacy and foster a collaborative atmosphere for shared governance in drug safety [1]

Group 1 - Hainan has become the first province in China to establish regulatory documents for the circulation management of antibacterial drugs, creating a comprehensive management system for the entire process of production, operation, and use of these drugs [1] - The newly introduced regulations detail requirements for sales management, quality management, prescription review, medication guidance, and product traceability, emphasizing the responsibility of enterprises and personnel for drug safety [1] - The regulations aim to prevent the misuse of antibacterial drugs, which can lead to drug abuse and bacterial resistance, by focusing on retail channels and prescription reviews to prevent illegal distribution [1] Group 2 - Hainan has conducted multiple safety actions over the past three years to strengthen drug retail supervision, addressing issues such as illegal drug purchases, improper sales of prescription drugs, and unlicensed pharmacists [2] - The "Clean Source" action this year has inspected 3,342 retail pharmacies, ordered 311 companies to rectify issues, and initiated 99 legal cases, with three cases referred to law enforcement, ensuring stability in the drug circulation market [2] - The province has implemented a drug traceability platform to enhance the transparency of drug sources and destinations in retail pharmacies [2]

Group 1 - The core focus of the news is the "Qingyuan" action initiated by the Tai'an Market Supervision Administration to enhance drug safety and address public concerns regarding drug management [1][2] - The action has been integrated into the annual drug regulation key task list, with a detailed work plan established in collaboration with the municipal administrative approval service bureau [1] - A specialized task force has been formed, consisting of three functional groups: comprehensive, supervision inspection, and case handling, to ensure effective implementation of the action [1] Group 2 - The "Qingyuan" action targets illegal online drug sales, expired and counterfeit drugs, and the unauthorized sale of prescription drugs, focusing on key units and products [2] - Comprehensive inspections are being conducted using on-site checks and online monitoring to effectively combat illegal activities and create a deterrent effect [2] - The Tai'an Market Supervision Administration plans to deepen the "Qingyuan" action by increasing risk assessment efforts and investigating illegal leads to ensure public safety in drug use [2]